Seach medical group engages in propagation, cultivation, manufacture, and sale of medical cannabis products, in accordance with the most rigid standards. The company operates, directly or by its subsidiaries, for the development of unique genetics, cannabis-based products, innovative technologies and other ancillary products. Seach Medical Group executes breakthrough clinical trials with leading research institutions, with the goal of developing innovative and high-quality cannabis products for the good of the patients. The company operates in Israel and worldwide for more than a decade and considered as a pioneer in the medical cannabis field. The company’s shares are traded on the Tel Aviv Stock Exchange under the symbolic SEMG.TA, starting as of September 4, 2019.